Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in&nbsp;patients with chronic heart failure

Original Research

Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

Total article views		HTML views	PDF downloads	Totals
20,737	Dovepress*	18,485+	1,494	19,979
	PubMed Central*	2,252	848	3,100
	Totals	20,737	2,342	23,079
*Since 5 August 2015 +Since July 2016